baber/WOPTO huggingface dataset:
Patent NZ-244596-A (NZ)
Title: Synchroniser for asynchronous transfer mode digital network terminal equipment
Inventor: RENAULT DENIS
IPC: H04L12/70
Filed: 1992-10-02
Abstract: This synchronisation method for terminals connected to a so-called asynchronous transmission mode telecommunications network, including means (7) for filtering the transmission jitter introduced by such a network and affecting the rate of reception, via the said terminal, of the data routed through this network, and for slaving the frequency of a local clock signal delivered by a local clock internal to the said terminal, to that of the signal output by the said filtering means, includes a buffer memory (MTB1, MTB2), written with the said data, at their rate of reception by the said terminal, and means (5, 5') for reading this buffer memory, at the rate of the said signal output by the said filtering and slaving means, and with a delay, with respect to the writing, determined so as to minimise the risks related to the bit under-rate in the restoring of the data on completion of this reading, during the reaction times of the said filtering and slaving means, whilst remaining within an acceptable margin as regards the delay in the restoring of these data. <IMAGE>
Patent NZ-255655-A (NZ)
Title: Detoxification of mustard gas by contacting the gas with a bis-tertiary diamine to form a quaternary ammonium ionene polymer
Inventor: PUCKETT WALLACE E
IPC: A62D101/47
Filed: 1993-07-30
Abstract: A microbicidal composition comprising an aqueous solution containing a sulfur-containing quaternary ammonium ionene polymer comprising a repeating unit of formula II:   <CHEM> wherein X &upbar&  is a counter-ion; R<1> and R<2>, which can be the same or different, are selected from a lower alkyl group and -CH2-CH2-OH; A' is a radical selected from -S-, -S-CH2-CH2-S-, -S-S- and the oxidation products of -S-, of -S-CH2CH2-S- and of -S-S-; and B is a radical selected from C1-C5 alkyl, -CH2-CH(OH)-CH2-, and -(CH2)m-O-(CH2)m-, where each m is independently 1,2, or 3, and wherein said sulfur-containing quaternary ammonium ionene polymer is present in an amount effective to inhibit the growth of at least one microorganism.
Patent NZ-255857-A (NZ)
Title: Neutral aqueous soluble beta-glucans in triple helix conformation and pharmaceutical compositions thereof
Inventor: JAMAS SPIROS
IPC: A61P31/04
Filed: 1993-08-20
Abstract: PCT No. PCT/US93/07904 Sec. 371 Date Jan. 26, 1995 Sec. 102(e) Date Jan. 26, 1995 PCT Filed Aug. 20, 1993 PCT Pub. No. WO94/04163 PCT Pub. Date Mar. 3, 1994The present invention relates to neutral, aqueous soluble  beta -glucans which exert potent and specific immunological effects without stimulating the production of certain cytokines, to preparations containing the novel  beta -glucans, and to a novel manufacturing process therefor. The neutral, aqueous soluble  beta -glucan preparation has a high affinity for the  beta -glucans receptor of human monocytes and retains two primary biological (or immunological) activities, (1) the enhancement of microbicidal activity of phagocytic cells, and (2) monocyte, neutrophil and platelet hemopoietic activity. Unlike soluble glucans described in the prior art, the neutral, aqueous soluble  beta -glucans of this invention neither induces nor primes IL-1 beta  and TNF alpha  production in vitro and in vivo. Safe and efficacious preparations of neutral, aqueous soluble  beta -glucan of the present invention can be used in therapeutic and/or prophylactic treatment regimens of humans and animals to enhance their immune response, without stimulating the production of certain biochemical mediators (e.g., IL-1 beta , TNF alpha ) that can cause detrimental side effects, such as fever and inflammation.
Patent NZ-260588-A (NZ)
Title: Imidazole derivatives and opthalmic compositions thereof
Inventor: MICHEL PHILIPPE
IPC: A61K31/415
Filed: 1994-05-24
Abstract: 2-Hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]benzenecarboximidamides and their salts, processes for their preparation and ophthalmic compositions containing them. These new compounds correspond to the general formula: <IMAGE>  in which     R1 = hydrogen or C1-4 alkyl;   R2 = hydrogen, hydroxyl, amino or C1-4 alkyl;   R3 = hydrogen; or   R2 and R3 = -CH2-CH2-.   These are new compounds which are capable of lowering intraocular pressure and which can be used in the treatment and prevention of glaucoma.
Patent NZ-264320-A (NZ)
Title: Piperidine derivatives and medicaments
Inventor: MOHACSI ERNO
IPC: A61P25/28
Filed: 1994-08-26
Abstract: Compounds of the formula <CHEM>     wherein   R   is hydrogen, hydroxy, or aryl lower alkyloxy; X   is hydrogen; Y   is hydroxy or hydrogen;     or both X and Y taken together are oxygen;   Z   is aryl lower alkyl; and m   is an integer from 1 to 4 or a diastereomer or an enantiomer thereof, except, the R,R diastereomer of formula I, wherein X is hydrogen, Y is hydroxy, R is benzyloxy, Z is benzyl, and m is 1, or pharmaceutically acceptable salts thereof, reduce adverse effects of toxic injury to central neurons and thus are useful in the treatment of ischemia, stroke, hypoxia and are NMDA receptor antagonists.
Patent NZ-264328-A (NZ)
Title: Air freshening refill sprayer device has a spray container inside a refill shroud with a flexing device
Inventor: ADAMS MARY BETH
IPC: B05B9/04
Filed: 1994-08-29
Abstract: The refill package for use within an outer shell having guides, comprises a spray container having a can body and a valve which includes s valve stem, a base, and an exterior shroud into which the spray container is inserted. The shroud has a spray nozzle and means to lock the spray container position so that the valve stem is in communication with the spray nozzle. The spray nozzle is fitted over the container in fluid communication with the valve stem. The spray nozzle is attached to the can body by a flexing section having a sufficient range of motion to allow the valve to be actuated when pressure is applied to the spray nozzle.
Patent NZ-302913-A (NZ)
Title: Method and apparatus for cryopreservation of mammalian skin, cultured skin or cornea equivalent
Inventor: WATSON STEPHEN R
IPC: B65D77/04
Filed: 1996-01-30
Abstract: This invention is directed to an efficient cryopreservation package design of harvested mammalian tissues and living cultured tissue equivalents made by in vitro technology. The invention involves immersing a mammalian tissue or cultured tissue equivalent in a cryoprotectant solution, agitating the cryoprotectant solution and the immersed tissue to achieve effective penetration of the cryoprotectant solution into the tissue, and then freezing the tissue at a very slow freezing rate. In the freezing step, extracellular ice formation is initiated by seeding. The cryopreserved tissue may be stored for indefinite periods of time prior to use. The cultured tissue equivalent is an in vitro model of the equivalent human tissue, such as skin or cornea, which, when retrieved from storage can be used for transplantation or implantation in vivo or for screening compounds in vitro. <IMAGE>
Patent NZ-304988-A (NZ)
Title: 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives and their use
Inventor: KAI NAOKI
IPC: C07D317/70
Filed: 1996-04-12
Abstract: isclosed are 1-[w-(3,4-Dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives represented by general formula (I) and salts and N-oxide derivatives thereof, wherein R1 and R2 represent each hydrogen, halogeno, hydroxy, alkyl, alkoxy, hydroxymethyl, etc., or R1 and R2 form together methylenedioxy, trimethylene, etc.; R3 represents hydrogen, etc.; R4 represents hydrogen, hydroxy, alkyl, etc.; R5 represents hydrogen, alkyl, etc.; p is an integer of from 2 to 6; and q is an integer of from 3 to 7; excluding the case where R1, R2, R3, R4 and R5 are all hydrogen, p is 2 and q is 5.  The compounds have a potent effect of suppressing urinary reflex and thus are useful as a remedy for frequent urination and urinary incontinence.
Patent NZ-330234-A (NZ)
Title: Process for preparing crystalline sodium diformylamide
Inventor: EVANS JONATHAN CHARLES
IPC: C07C233/90
Filed: 1995-09-18
Abstract: The present invention relates to a novel process for preparing (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, also known in the art as (E)-(p-fluorophenethyl)-3-fluoroallylamine, and novel intermediates thereof (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane is useful as an irreversible inhibitor of monoamine oxidase.
Patent NZ-332003-A (NZ)
Title: Door mat, array of panels joined by flexible separators, extending in 2 dimensions
Inventor: MACINTYRE PETER CURRIE
IPC: B60N3/04
Filed: 1998-09-23
Abstract: A flexible mat, consisting of substantially rigid, flat panels joined by flexible separators, that extends in two dimensions is disclosed. The separators are such that they are attached to the lower face of the panels and allow the mat to be rolled up as they introduce a fixed space between the panels. A substantial number of the separators are attached to the borders of 4 panels. This mat is useful in an entranceway, and may also include ridges on the edges of the panels suitable for scraping shoes. It can be manufactured to specific dimensions by using an appropriate number of panels and connectors.
Patent NZ-336087-A (NZ)
Title: Animal head removal by driving an axe-like blade with sufficient force and velocity to sever the head even if the preferred spot is missed
Inventor: LEE ALLAN PHILIP
IPC: A22B5/00
Filed: 1999-06-14
Abstract: Axe-like blade 30 is moved at sufficient force and velocity such that a slaughtered animal's head is severed even if the blade misses the preferred spot of the atlas joint.
Patent NZ-336826-A (NZ)
Title: Industrial antimicrobial/mildew-proofing agents, algicides and antifouling agents containing N-quinoxalylanilines
Inventor: IGARASHI SHINICHI
IPC: A01N43/60
Filed: 1998-01-21
Abstract: An industrial antibacterial/antifungal agent, algicide and an agent for preventing the adhesion of organisms, containing at least one compound of N-quinoxalylanilines as represented by the above formula, wherein: R1 and R2 each independently represent H, halogen, CF3, C1-C5 alkyl, C1-C5 alkoxy or NO2 R3 represents H, halogen or C1-C5 alkyl R4 represents H, C1-C5 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C2-C6 alkylcarbonyl, C1-C5 alkylsulfonyl or C1-C5 alkylsulfenyl.  The alkylsulfenyl group may be substituted with halogen. X and Y independently represent NO2, CF3 or halogen Z represents H, halogen, NO2 or OH m and n each independently represent 0 or 1, but not m=n=1 j and k each independently represent 0, 1, 2 or 3 provided that j+k<3
Patent NZ-336856-A (NZ)
Title: Dietary supplements comprising extract from green lipped mussel and one from deer velvet, Enzogenol and shark cartilage to treat inflammation
Inventor: KEITH DAVID MCSPORRAN
IPC: A23L17/40
Filed: 1999-07-21
Abstract: Described is a composition for administration to animals suffering from arthritis, inflammation or chronic joint pain.  The composition contains:  at least one anti-inflammatory agent selected from:  green-lipped mussel extract (GLME) and  shark cartilage; with at least one enhancing agent selected from: a bark product or extract exhibiting antioxidant properties and shark cartilage. The composition must include one member from each group and the selected members must be different.
Patent NZ-503424-A (NZ)
Title: Stabilised hair care products containing water insoluble organosilicone compounds
Inventor: PATEL AMRIT
IPC: A61Q5/02
Filed: 1998-09-10
Abstract: A method for stabilising a water-insoluble organosilicone compound in a hair care product.  The method comprises combining an anionic detersive surfactant, a water insoluble silicone conditioning agent, an acrylic stabilising agent of formula III or formula IV; where R10 is a member of the group consisting of hydrogen and C1-22 alkyl and n is an integer from 3-4100, and where R11 and R12 are each independently selected from the group defined by R10 and m is an integer from 3-4100, and where a neutralisation step is performed with a member of the group consisting of cosmetically acceptable bases, with water or another aqueous medium.
Patent NZ-505861-A (NZ)
Title: Use of inorganic particles comprising chemical elements in a predefined ratio in marking means
Inventor: ROZUMEK OLIVIER
IPC: C09D7/12
Filed: 1998-12-22
Abstract: Use  of at least one inorganic particle comprising  at least   one  predefined  ratio  of  at  least  two  chemical elements  as  a marking means, wherein the predefined  ratio represents a code or a part of a code and wherein  inorganic particle  is  selected  from the group  consisting  of  non- stoichiometric crystalline compounds is disclosed. These marking means having multi-layered thin film particles are  used  as  a  tag.   The sequence  and/or  thickness  of individual  layers  that  are  distinct  in  their  chemical composition  are analytically identifiable and  represent  a code.   Thus  the incorporation in any organic or  inorganic material  provides  the  product  formed  thereof  with   an undistinguishable  feature.  A preferred embodiment  is  the incorporation  of  the  encoded  particles  in   a   coating composition  and  printing ink that are useful  for  marking security   documents.   Additionally  a  strong   protection against  illicit  reproduction  is  achievable  by  applying these encoded particles.
Patent NZ-507154-A (NZ)
Title: Communication plug characterised by a Z-shaped clip which is depressed to facilitate entry or release from a socket
Inventor: TANG TSUN-YI
IPC: H01R13/627
Filed: 2000-09-25
Abstract: A clip guard (331) protruding from a protective cable cover (33) is described. The cable cover is bonded with the cable jack so that it is no longer detachable. The clip guard is in contact with a clip (32), which only requires a very small force to lower the clip (32) when releasing the cable jack from a telecommunications socket.
Patent NZ-507372-A (NZ)
Title: Window or door frame member(s) with architrave portion extending around aperture and engaging with side member, typically reveal, by fasteners
Inventor: BAXTER JEFFERY HUGH
IPC: E06B1/60
Filed: 2000-10-09
Abstract: Frame member 2 has first portion in the form of skirt 7 forming an architrave around the outside of a window (or door) aperture. Second portion 8 receives aperture closure (window shown here). Third portion 9 receives aperture side member or reveal 5. Portion 9 has pins 10 which engage bores in member 5 so that member 5 is slidably engagable with member 2 when the latter is in place in the aperture. This is stated to provide the advantage of fitting external and internal wall linings 15, 16 prior to fitting the window frame.
Patent NZ-509967-A (NZ)
Title: Methods of treatment using thiazoline acid derivatives
Inventor: BERGERON RAYMOND J
IPC: C07D277/12
Filed: 1997-03-31
Abstract: Disclosed is a method of treating a pathological condition in a non-human mammal associated with an excess of a trivalent metal, ion of compound there of comprising administering to the animal a compound of the formulas I-VI, wherein: R may be H or acyl; R1, R2, R3, R4 and R7 may be the same or different and represent H, alkyl or hydrocarbyl arylalkyl having up to 14 carbon atoms, or ûCH2-[O-(Ch2)x]y-OCH3, wherein x is 1-10 and y is 0-10; R5 is H, alkyl having up to 15 carbon atoms, ûCH2)1-2-[O-(Ch2)x]y-OCH3, wherein x is 1-10 and y is 0-10, or ûCH2-NOH-CO-[(Ch2)z-NOH-CO]q-R1, wherein R1 is as defined above, z is 1-10 and q is 0-5; R6 is H or acyl; n is 0-10; or a salt thereof with a pharmaceutically acceptable acid or a pharmaceutically acceptable complex thereof. (62) Divided out of 332049
Patent NZ-513061-A (NZ)
Title: Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the treatment of diabetic neuropathy
Inventor: CAMERON NORMAN EUGENE
IPC: A61K31/427
Filed: 2000-02-01
Abstract: (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulphonyl)amino]pyrimidin-5-yl] (3R, 5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof is used in the manufacture of a medicament to treat diabetic neuropathy optionally with another drug useful for treating diabetes or the complications of diabetes such as insulin, troglitazone, rosiglitazone, pioglitazone, MCC-555, (S)-2-ethoxy-3-[4-(2-{4-methanesulphonyloxyphenyl}ethoxy)phenyl]propanoic acid, 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(S)-2-ethoxypropanoic acid, glimepiride, glibenclamide, gliclazide, glipizide, gliquidone, tolazamide, metformin, acarbose or repaglinide.
Patent NZ-513932-A (NZ)
Title: Plants and feed baits for controlling damage from feeding insects
Inventor: DALL DAVID JAMES
IPC: A01N63/40
Filed: 2000-03-10
Abstract: Plants are disclosed which are capable of expressing, in tissues susceptible to damage by feeding insects, exogenous proteins such as fusolin or a fusolin-like protein, to reduce damage to the plant by inhibiting feeding, growth and/or development of insects.  Feed baits comprising spindle bodies, spindle-like bodies or constituent proteins thereof, which inhibit feeding, growth and/or development of insects are also disclosed.
Patent NZ-515382-A (NZ)
Title: OX2 receptor homologs
Inventor: BARCLAY A NEIL
IPC: A61K48/00
Filed: 2000-05-11
Abstract: Nucleic acids encoding mammalian, e.g., primate, receptors of OX2, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Method of using the compositions for both diagnostic and therapeutic utilities are described.
Patent NZ-518466-A (NZ)
Title: Manufacture of paper and paperboard
Inventor: RICHARDSON GARY PETER
IPC: D21H17/68
Filed: 2000-11-02
Abstract: A process of making paper or paper board comprising forming a cellulosic suspension, flocculating the suspension with a cationic material, draining the suspension on a screen to form a sheet and then drying the sheet, wherein the suspension is flocculated using a flocculation system comprising a water soluble cationic polymer, a siliceous material and an anionic branched water soluble polymer that has been formed from water soluble ethylenically unsaturated anionic monomer or monomer blend and branching agent and wherein the anionic polymer has (a) intrinsic viscosity of at least 4.0 dl/g and (b) rheological oscillation value of tan delta at 0.005 Hz of above 0.7 and/or (c) deionised SLV viscosity number which is at least three times the salted SLV viscosity number of the corresponding unbranched polymer made in the absence of branching agent.  The water soluble cationic polymer is added to the cellulosic suspension and then the suspension is mechanically sheared, after which the siliceous material and anionic polymer are added.
Patent NZ-518671-A (NZ)
Title: Spiro (2H-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors
Inventor: GIBSON SAMUEL GEORGE
IPC: A61P25/16
Filed: 2000-11-13
Abstract: Compounds of formula (I), wherein: the dotted line is an optional bond, Y is 1-4 substituents independently selected from H, halo, optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heteroaryl, or 2 Y substituents together may form O- (CH2)n-O or O-(CF2)n-O, wherein n is 1 or 2, X is 1-3 substituents independently selected from H, halo, hydroxy, alkyloxy, SR3, NR3SO2R4 or halo-substituted alkyl, R1 is H, alkyl or aryl, R2, R3 and R4 are H or alkyl. The compounds are used in the manufacture of medicaments that have CNS activity.
Patent NZ-520831-A (NZ)
Title: Portable fencing system and components therefor
Inventor: PULLIAM BRYAN J
IPC: E04H17/08
Filed: 2001-01-19
Abstract: A winch corner fixture useful in a portable fencing system, comprising: (a) a main support frame (20) having at least three mounting portions (28) angularly displaced from one another about a central vertical axis of the main support frame; (b) means (30) for securing portions of a fence wire to the main support frame; (c) a plurality of at least three spaced apart leg members (22) each pivotally mounted to one of the three mounting portions of the main support frame such that the leg members can be set up in a tripod configuration about the central vertical axis of the support frame with the leg members angularly displaced from one another about the central vertical axis at the same angular displacements of the three mounting portions of the support frame from one another; and (d) a winch assembly (44, 46, 48) supported on the main support frame above the three mounting portions thereof.
Patent NZ-525882-A (NZ)
Title: Cream deodorising system and method
Inventor: BURT CHRISTOPHER ROSS
IPC: A01J11/00
Filed: 2003-05-14
Abstract: A system and method for treating cream to deodorize the cream is disclosed in which a treatment vessel is provided for receiving the cream. Steam is supplied to the vessel so that the steam flows in countercurrent to the cream flowing through the vessel and infuses into the cream to thereby deodorize the cream in the vessel. The steam is collected by a steam collection means in the form of a condenser vessel which has a heat exchanger. The heat exchanger is heated by the steam collected in the vessel so as to heat water which is supplied to a pasteurizer which pasteurizes the cream. First and second flash off vessel to perform further deodorizing of the cream from the vessel to perform further deodorizing of the cream by drawing material from the cream. The vessel has an upper chamber 152 and a plurality of tubes 94 in communication with the upper chamber and an outlet at the bottom of the vessel. A distributor 99 is provided in the upper chamber 152 for distributing the cream over a plate 154 so the cream can flow through holes in the plate and through the tubes with steam passing up through the tubes in order to deodorize the cream.
Patent NZ-527899-A (NZ)
Title: Polypeptides and nucleic acids with homology to acid-labile subunit of insulin-like growth factor
Inventor: BAKER KEVIN P
IPC: C12N5/08
Filed: 1998-12-01
Abstract: Disclosed are PRO357 proteins and to nucleic acid molecules encoding those polypeptides having homology to the acid labile subunit of insulin-like growth factor, and thought to be involved in protein-protein interactions. Also disclosed are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. (62) Divided out of 522634
Patent NZ-531689-A (NZ)
Title: Flexible wrap kit and methods
Inventor: TOUSSANT JOHN WILLIAM
IPC: C09J7/02
Filed: 2002-10-25
Abstract: Flexible wrap kits comprise a flexible film and an adhesive component wherein the adhesive component is adapted for application to the flexible film or an article for adhering the flexible film and the article upon contact therebetween, and wherein the kits are suitable for use in methods for adhering an article with the flexible film. In specific embodiments, the flexible film comprises plastic films, wax papers or metallic foil wraps.